6 completed, 3 not yet recruiting, 2 recruiting, 1 terminated. 5 Not applicable, 2 Phase 2, 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Not yet recruiting 2, Recruiting 2, Completed 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 4 | 2 | Not yet recruiting 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Skin Lesions: new trials by email Literature Review of Skin Lesions trials Research Report on Skin Lesions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human-AI Uncertainty Callibration for Improved Skin Lesion Segmentation Base Model, FDM - Skin Lesions | Not applicable | Not yet recruiting | Copenhagen Academy for Medical Education and Simulation | 50 | 2026-03-01 | 2026-03-12 |
| Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care Intervention with telemedicine tool - Skin Cancer Prevention, Melanoma In Situ | Not applicable | Recruiting | Institute of Health Information and Statistics of the Czech Republic | 1440 | 2026-02-01 | 2026-03-27 |
| Paraffin Oil for Preventing Tourniquet-Related Skin Lesions in Upper Extremity Surgery Paraffin Oil - Pressure Injury, Skin Lesions | Not applicable | Recruiting | Istanbul Medipol University Hospital | 90 | 2026-01-12 | 2026-06-04 |
| Evaluation of the EF192B Protection Versus No Treatment EF192B - Skin Lesions, Skin Care | Not applicable | Not yet recruiting | Eurofarma Laboratorios S.A. | 72 | 2025-08-31 | 2024-12-30 |
| Prevention and Treatment for Bruises in Patients With Ischemic Stroke Ascorbic acid (Vitamin C), Normal Saline (Placebo) - Stroke, Bruises | Phase 4 | Not yet recruiting | Chiayi Christian Hospital | 400 | 2025-08-01 | 2025-02-13 |
| Assessment of EF192A Potential Sensitization and Accumulated and Primary Irritability in Controlled/Maximized Conditions EF192A, Saline solution - Skin Lesion, Skin Lesions | Not applicable | Completed | Eurofarma Laboratorios S.A. | 88 | 2025-01-20 | 2025-06-15 |
| Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions. AI-based medical device for aided diagnosis in dermatological conditions - Skin Lesions, Melanocytic Nevi | Completed | AI Labs Group S.L | 9 | 2024-06-04 | 2026-02-24 | |
| The Validation of New Photographic Technology for Assessing Skin Lesions Skin Lesions | Completed | Wright State University | 200 | 2023-02-15 | 2025-02-06 | |
| Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers PRP+HA, HA - Diabetic Foot Ulcer, Skin Lesions | Phase 1 / Phase 2 | Completed | Ospedale Policlinico San Martino | 72 | 2021-02-23 | 2024-11-08 |
| Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex Aspirin, AED, Placebo - Tuberous Sclerosis Complex, Aspirin | Phase 2 | Unknown | Peking Union Medical College Hospital | 98 | 2017-11-20 | 2020-06-09 |
| Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging Skin Lesions | Completed | Orlucent, Inc | 357 | 2016-07-01 | 2020-11-18 | |
| Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection. Skin Lesions | Completed | Orlucent, Inc | 126 | 2013-06-01 | 2018-02-19 | |
| Tolerance Study of the Silicone Bands on Medical Compression Stockings Innothera's brand Stockings, Stockings other than Innothera's brand - Skin Lesions | Phase 4 | Terminated | Laboratoires Innothera | 3 | 2011-11-01 | 2014-08-08 |
| VivaNet Study. A Multicenter Study of Confocal Reflectance Microscopy in Telemedicine Skin Cancer, Skin Lesions | Withdrawn | Lucid, Inc. | 2011-04-01 | 2019-11-08 |
Melanoma (3) · Skin Neoplasms (3) · Carcinoma, Basal Cell (1) · Cognitive Dysfunction (1) · Contusions (1) · Diabetic Foot (1) · Epilepsy (1) · Hemorrhage (1) · Hidradenitis Suppurativa (1) · Keratosis, Actinic (1) · Nevus (1) · Nevus, Pigmented (1) · Pressure Ulcer (1) · Seizures (1) · Skin Diseases (1)
Skin and Connective Tissue Diseases (6) · Neoplasms (5) · Skin Diseases (5) · Neoplasms by Site (4) · Neoplasms by Histologic Type (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Nerve Tissue (3) · Neuroectodermal Tumors (3) · Neuroendocrine Tumors (3) · Nevi and Melanomas (3) · Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2)
Abortion, Induced (1) · Anticonvulsants (1) · Ascorbic Acid (1) · Aspirin (1) · Mineral Oil (1) · Saline Solution (1)
Eurofarma Laboratorios S.A. (2) · Orlucent, Inc (2) · AI Labs Group S.L (1) · Chiayi Christian Hospital (1) · Copenhagen Academy for Medical Education and Simulation (1) · Institute of Health Information and Statistics of the Czech Republic (1) · Istanbul Medipol University Hospital (1) · Laboratoires Innothera (1) · Lucid, Inc. (1) · Ospedale Policlinico San Martino (1) · Peking Union Medical College Hospital (1) · Wright State University (1)
Brazil (2) · Italy (2) · Spain (2) · China (1) · Czechia (1) · France (1) · Israel (1) · Turkey (Türkiye) (1) · United States (1)
Antonio Martorell, PhD (1) · Giovanni Pellacani, MD (1) · Giovanni Pratesi, MD (1) · Josep Malvehy, MD (1) · Martin Tolsgaard, Professor (1) · Petr Arenberger, prof. (1) · Qing Liu, MD PhD (1) · Shokrey Kassis, MA (1) · Yehuda Ullmann, MD (1)
PMID 11573006, PMID 14671251, PMID 16078959, PMID 19003734, PMID 19558476, PMID 19874953, PMID 20083041, PMID 21916138, PMID 24284213, PMID 25185110, PMID 26756058, PMID 26988952, PMID 27843871, PMID 29040244, PMID 29766750, PMID 29995458, PMID 30589927, PMID 31610718, PMID 32754902, PMID 32809003, PMID 33517432, PMID 34448547, PMID 34495877, PMID 35131720, PMID 35306630, PMID 36156315, PMID 36762865, PMID 37278679, PMID 37806002, PMID 7787644, PMID 9788453